NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
231 Jönköping |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 61 | 0.7% | 4 | 0.0% | . | . | 2 | 0.0% | . | . | 1 | 0.0% | 3 | 0.0% | 8927 | 99.2% | 8998 | 100.0% |
ASCUS | 180 | 28.2% | 91 | 14.2% | . | . | 64 | 10.0% | . | . | 1 | 0.2% | 32 | 5.0% | 271 | 42.4% | 639 | 100.0% |
CIN1 | 58 | 22.9% | 73 | 28.9% | . | . | 43 | 17.0% | . | . | 1 | 0.4% | 11 | 4.3% | 67 | 26.5% | 253 | 100.0% |
Atypical glandular cells/AGC | 2 | 16.7% | 2 | 16.7% | . | . | 2 | 16.7% | 2 | 16.7% | 2 | 16.7% | . | . | 2 | 16.7% | 12 | 100.0% |
Unclear atypia | 3 | 27.3% | 2 | 18.2% | . | . | 4 | 36.4% | . | . | 1 | 9.1% | 1 | 9.1% | . | . | 11 | 100.0% |
ASC-H | 10 | 20.4% | 5 | 10.2% | . | . | 32 | 65.3% | . | . | 1 | 2.0% | 1 | 2.0% | . | . | 49 | 100.0% |
CIN3 | 6 | 5.9% | 11 | 10.9% | . | . | 76 | 75.2% | 1 | 1.0% | 5 | 5.0% | 2 | 2.0% | . | . | 101 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | . | . | . | . | 1 | 100.0% |
Malignant tumor with unclear origin | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | . | . | . | . | 1 | 100.0% |
Squamous cell cancer | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | . | . | . | . | 1 | 100.0% |
Total | 320 | 3.2% | 188 | 1.9% | . | . | 226 | 2.2% | 3 | 0.0% | 12 | 0.1% | 50 | 0.5% | 9267 | 92.1% | 10066 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81401, M81403, M83803 |